Related references
Note: Only part of the references are listed.Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system
Amir Abbas Momtazi-Borojeni et al.
ATHEROSCLEROSIS (2019)
Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer
Amir Abbas Momtazi-Borojeni et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Effects of immunization against PCSK9 in an experimental model of breast cancer
Amir Abbas Momtazi-Borojeni et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy
Aruna D. Pradhan et al.
CIRCULATION (2018)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P. Bonaca et al.
CIRCULATION (2018)
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Neil Ruparelia et al.
NATURE REVIEWS CARDIOLOGY (2017)
PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia
Sophie J. Bernelot Moens et al.
EUROPEAN HEART JOURNAL (2017)
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
Christine Landlinger et al.
EUROPEAN HEART JOURNAL (2017)
PCSK9 and Atherosclerosis - Lipids and Beyond
Michael D. Shapiro et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
Zhi-Han Tang et al.
ATHEROSCLEROSIS (2017)
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subtractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Amos Baruch et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
PCSK9 regulates the chemokine receptor CCR2 on monocytes
Jana Grune et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Reducing Vascular Calcification by Anti-IL-1 Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia
Zuhier Awan et al.
ANGIOLOGY (2016)
Prognostic value of PCSK9 levels in patients with acute coronary syndromes
Baris Gencer et al.
EUROPEAN HEART JOURNAL (2016)
Local effects of human PCSK9 on the atherosclerotic lesion
Ilaria Giunzioni et al.
JOURNAL OF PATHOLOGY (2016)
Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis
Zufeng Ding et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement
Nicola Ferri et al.
ATHEROSCLEROSIS (2016)
Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms
Amirhossein Sahebkar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
DIFFERENTIAL EXPRESSION OF PCSK9 MODULATES INFECTION, INFLAMMATION, AND COAGULATION IN A MURINE MODEL OF SEPSIS
Dhruva J. Dwivedi et al.
SHOCK (2016)
Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease
Sha Li et al.
ANNALS OF MEDICINE (2015)
Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
Zufeng Ding et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
Rainer Schulz et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
Cross-talk between LOX-1 and PCSK9 in vascular tissues
Zufeng Ding et al.
CARDIOVASCULAR RESEARCH (2015)
TLR4/NF-κB Signaling Contributes to Chronic Unpredictable Mild Stress-Induced Atherosclerosis in ApoE-/- Mice
Ya Ling Tang et al.
PLOS ONE (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
Sha Li et al.
ATHEROSCLEROSIS (2014)
PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells
Thomas A. Lagace
CURRENT OPINION IN LIPIDOLOGY (2014)
Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease
Yan Zhang et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE
Brandon Ason et al.
JOURNAL OF LIPID RESEARCH (2014)
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
Susan Kuhnast et al.
JOURNAL OF LIPID RESEARCH (2014)
PCSK9 is a critical regulator of the innate immune response and septic shock outcome
Keith R. Walley et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
LOX-1, OxLDL, and Atherosclerosis
Angela Pirillo et al.
MEDIATORS OF INFLAMMATION (2013)
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
Nicola Ferri et al.
ATHEROSCLEROSIS (2012)
Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice
Maxime Denis et al.
CIRCULATION (2012)
Inflammation in Peripheral Arterial Disease (PAD)
Salvatore Santo Signorelli et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
Zhihan Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
Frances Wensley et al.
BRITISH MEDICAL JOURNAL (2011)
Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
George S. Abela
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Molecular basis of PCSK9 function
Gilles Lambert et al.
ATHEROSCLEROSIS (2009)
Inflammation and Plaque Vulnerability
Prediman K. Shah
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice
Jian Guo et al.
CARDIOVASCULAR RESEARCH (2009)
Inflammation stimulates the expression of PCSK9
Kenneth R. Feingold et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet
Jawahar L. Mehta et al.
CIRCULATION RESEARCH (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Plaque stabilization: Can we turn theory into evidence?
Peter Libby et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Nuclear factor κB signaling in atherogenesis
MPJ de Winther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Vascular NADPH oxidases: molecular mechanisms of activation
RP Brandes et al.
CARDIOVASCULAR RESEARCH (2005)
Nuclear factor κB:: a potential therapeutic target in atherosclerosis and thrombosis
C Monaco et al.
CARDIOVASCULAR RESEARCH (2004)
C-reactive protein: Risk marker or mediator in atherothrombosis?
I Jialal et al.
HYPERTENSION (2004)
Oxidized phospholipids as modulators of inflammation in atherosclerosis
N Leitinger
CURRENT OPINION IN LIPIDOLOGY (2003)
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skålén et al.
NATURE (2002)
Scavenger receptors in innate immunity
L Peiser et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Function of C-reactive protein
TW Du Clos
ANNALS OF MEDICINE (2000)
Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species
L Cominacini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
